FDA Trend Report: Lower bar in the neurology division and what it means for biotech investing $XBI $ALKS $ACAD $SRPT $NBIX $BIIB $AMLX
There is something happening at the neurology department at the FDA. AND IT IS A POSITIVE DEVELOPMENT FOR DRUG DEVELOPMENT IN A VERY HIGHLY DIFFICULT SEGMENT OF DRUG DEVELOPMENT: NEUROLOGY…